Opportunity
Simpler Grants.gov #PAR-26-114
NIH Lasker Clinical Research Scholars Program Grant for Early-Stage Clinical Researchers
Buyer
National Institutes of Health
Posted
January 22, 2026
Respond By
August 28, 2026
Identifier
PAR-26-114
NAICS
541715
This opportunity from the National Institutes of Health (NIH) invites applications for the Lasker Clinical Research Scholars Program, designed to support early-stage clinical researchers focused on advancing human health. - Program Structure: - Two-phase program: 5-7 year tenure-track appointment within the NIH Intramural Research Program - Followed by up to 3 years of NIH support for research at an extramural facility or continued intramural appointment - Funding and Awards: - Estimated award value: $499,000 per recipient - Up to 5 awards expected - Eligibility: - Open to nonprofits, government agencies, educational institutions, and businesses - Foreign institutions are not eligible - Scope: - Covers research in areas such as heart, lung, blood diseases, sleep disorders, medical library assistance, child health, minority health, deafness, cardiovascular diseases, complementary health, neurosciences, cancer, and infectious diseases - No specific OEMs, vendors, or product procurements are involved, as this is a research grant - Unique Requirements: - Two-phase structure bridging NIH intramural and extramural research - Eligibility restrictions apply
Description
This Notice of Funding Opportunity (NOFO) encourages applications for the Lasker Clinical Research Scholars Program, which supports early-stage clinical researchers in their independent careers to improve human health. The program offers a unique bridge between NIH intramural and extramural research communities and consists of two phases: an initial 5-7 year tenure-track appointment within the NIH Intramural Research Program with independent research budgets, followed by up to 3 years of NIH support for research at an extramural facility or continuation within the intramural program. The program aims to foster clinical research and development through these phases.